Skip to content

Comparative study of EMLA cream and lidocaine tape on the reduction of the pain at arteriovenous fistula puncture in hemodialysis patients: A multicentre study.

Comparative study of EMLA cream and lidocaine tape on the reduction of the pain at arteriovenous fistula puncture in hemodialysis patients: A multicentre study. - Study of the painless effect at arteriovenous fistula puncture

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027885
Enrollment
68
Registered
2017-06-23
Start date
2017-06-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage renal disease requiring maintenance hemodialysis

Interventions

EMLA CREAM Youpatch tape

Sponsors

Kanazawa Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients receiving maintenance hemodialysis

Exclusion criteria

Exclusion criteria: 1. Past history of allergy for local anesthetics. 2. Past history of contact dermatitis for ointment 3. Severe hepatic disease 4. Methemogulobinemia 5. Porphyria 6. Pregnancy or lactation period 7. Dermal abnormality on the puncture site 8. Severe sensory disturbance in the limbs 9. Visual disturbance or hearing impairments 10. Patients with troubles when receiving vascular punctures over the last three hemodialysis treatments 11. Patients who are unable to communicate adequately with observers due to conditions such as consciousness disorder 12. Patients whom responsible doctors consider as inappropriate participants

Design outcomes

Primary

MeasureTime frame
Painless using Visual Analogue Scale (VAS)

Secondary

MeasureTime frame
Health-related quality of life using Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36)

Countries

Japan

Contacts

Public ContactKeiji Fujimoto

Kanazawa Medical University Nephrology

k-2210@kanazawa-mad.ac.jp076-286-2211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026